Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Myriad (MYGN) To Contact Him Directly To Discuss Their Options
If you purchased or acquired stock in Myriad and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.
Click here to participate in the action.
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) —
What’s Happening:
- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ:MYGN) on behalf of Myriad stockholders. Our investigation concerns whether Myriad has violated the federal securities laws and/or engaged in other unlawful business practices.
Investigation Details:
- On July 30, 2026, Myriad Genetics reported Q2 2026 revenue of approximately $190.7 million, down roughly 11% year-over-year and 7% to 8% below Wall Street consensus of approximately $206-$208 million. Simultaneously, the Company cut its full-year 2026 revenue guidance to $770-$790 million from approximately $860-$880 million, lowered gross margin expectations, and suspended its adjusted EBITDA guidance entirely – which had previously been set at $37-$49 million. Management attributed the shortfall to reimbursement pressure, collections issues, lower average revenue per test, and weaker prenatal performance. Following this news, Myriad’s stock price dropped. Notably, as recently as May 5, 2026, the Company had reiterated its full-year 2026 revenue guidance of $860-$880 million – a range that was slashed by approximately $90 million at the midpoint just three months later.
Next Steps:
- If you purchased or otherwise acquired Myriad shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities,
derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com
